In this study, wollastonite nanoparticles were synthesized and calcined at different temperatures. The resulting particles were added to a polymeric gelatin containing drug, and the gelatin/wollastonite nanocomposite was prepared as a carrier for gentamicin drug. The structure and morphology of the prepared particles and composites were evaluated using X-Ray Diffraction (XRD), Fourier Transform Infrared (FTIR) Spectroscopy, Field Emission Scanning Electron Microscopy (FESEM), and Transmission Electron Microscopy (TEM). The results showed the synthesis of single-phase wollastonite nanoparticles with sizes less than 10 nanometers, which agglomerate in some regions. The drug delivery rate in phosphate buffer solution, as analyzed by UV analysis at λmax=201 nm, indicated rapid degradation of the composite, with about 60% of the drug delivered in the initial hours and complete delivery after 2 days. Therefore, it can be concluded that the resulting composite is biodegradable and has the potential to be used as filler for bone defects and local drug delivery.
Amin, A. M., El-Amir, A. A., Karunakaran, G., Kuznetsov, D., & Ewais, E. M. (2021). In-vitro evaluation of wollastonite nanopowder produced by a facile process using cheap precursors for biomedical applications. Ceramics International, 47(13), 18684-18692. https://doi.org/10.1016/j.ceramint.2021.03.201
Arcos, D., Ragel, C. V., & Vallet-Regı, M. (2001). Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials, 22(7), 701-708.https://doi.org/10.1016/S0142-9612(00)00233-7
Aydemir, T., Liverani, L., Pastore, J. I., Ceré, S. M., Goldmann, W. H., & Boccaccini, A. R. (2020). Functional behavior of chitosan/gelatin/silica-gentamicin coatings by electrophoretic deposition on surgical grade stainless steel. Biomaterials, 31(22), 5865-5874. https://doi.org/10.1016/j.msec.2020.111062
Borhan, S., & Esmaeilzadeh, J. (2023). The Effect of Bioactive Glass Synthesis Method on the Flowability and Structural Stability of the Injectable Pastes Prepared from It. Journal of Advanced Materials and Technologies, 12(1), 1-15. [In Persian] https://doi.org/10.30501/jamt.2023.376241.1259
Chang, M. C., Ko, C. C., & Douglas, W. H. (2003). Preparation of hydroxyapatite-gelatin nanocomposite. Biomaterials, 24(17), 2853-2862. https://doi.org/10.1016/S0142-9612(03)00115-7
Chang, M. C., Ikoma, T., & Tanaka, J. (2004). Cross-linkage of hydroxyapatite/gelatin nanocomposite using EGDE. Journal of materials science, 39(16-17), 5547-5550. https://link.springer.com/article/10.1023/B:JMSC.0000039284.70028.fa
Chiani, E., Beaucamp, A., Hamzeh, Y., Azadfallah, M., Thanusha, A. V., & Collins, M. N. (2023). Synthesis and characterization of gelatin/lignin hydrogels as quick release drug carriers for ribavirin. International Journal of Biological Macromolecules, 224, 1196-1205. https://doi.org/10.1016/j.ijbiomac.2022.10.205
Das, M. P., Suguna, P. R., Prasad, K. A. R. P. U. R. A. M., Vijaylakshmi, J. V., & Renuka, M. (2017). Extraction and characterization of gelatin: a functional biopolymer. Int. J. Pharm. Pharm. Sci, 9(9), 239. 22159/ijpps.2017v9i9.17618
Dorozhkin, S. V. (2011). Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications. Biomatter, 1(2), 121-164. https://doi.org/10.4161/biom.18790
Hench, L. L., Splinter, R. J., Allen, W. C., & Greenlee, T. K. (1971). Bonding mechanisms at the interface of ceramic prosthetic materials. Journal of biomedical materials research, 5(6), 117-141. https://doi.org/10.1002/jbm.820050611
Huang, X., & Brazel, C. S. (2001). On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. Journal of controlled release, 73(2-3), 121-136. https://doi.org/10.1016/S0168-3659(01)00248-6
Khorsand Zak, A., Yousefi, R., Abd Majid, W. H., & Muhamad, M. R. (2012). Facile synthesis and X-ray peak broadening studies of Zn1− xMgxO nanoparticles. Ceramics International, 38(3), 2059-2064. https://doi.org/10.1016/j.ceramint.2011.10.042
Kim, H. W., Kim, H. E., & Salih, V. (2005). Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin–hydroxyapatite for tissue engineering scaffolds. Biomaterials, 26(25), 5221-5230. https://doi.org/10.1016/j.biomaterials.2005.01.047
Kokubo, T., Kushitani, H., Sakka, S., Kitsugi, T., & Yamamuro, T. (1990). Solutions able to reproduce in vivo surface‐structure changes in bioactive glass‐ceramic A‐ Journal of biomedical materials research, 24(6), 721-734. https://doi.org/10.1002/jbm.820240607
Kokubo, T. (1998). Apatite formation on surfaces of ceramics, metals and polymers in body environment. Acta materialia, 46(7), 2519-2527. https://doi.org/10.1016/S1359-6454(98)80036-0
Lakshmi, R., & Sasikumar, S. (2015). Influence of needle-like morphology on the bioactivity of nanocrystalline wollastonite–an in vitro study. International journal of nanomedicine, 10(sup2), 129-136. https://www.tandfonline.com/doi/pdf/10.2147/IJN.S79986
Lao, J., Dieudonne, X., Fayon, F., Montouillout, V., & Jallot, E. (2016). Bioactive glass–gelatin hybrids: Building scaffolds with enhanced calcium incorporation and controlled porosity for bone regeneration. Journal of Materials Chemistry B, 4(14), 2486-2497. https://doi.org/10.1039/C5TB02345A
Mollaqasem, V. K., Ardakani, M. H., & Hesaraki, S. (2013). Effects Bone Regeneration Using Nanotechnology–Calcium Silicate Nano-Composites. Journal of Research in Science, Engineering and Technology, 1(04), 1-4.
Nabipour, Z., Nourbakhsh, M. S., & Baniasadi, M. (2018). Evaluation of ibuprofen release from gelatin/hydroxyapatite/polylactic acid nanocomposites. Iranian Journal of Pharmaceutical Sciences, 14(1), 75-84.https://doi.org/10.22034/IJPS.2018.32051
Palakurthy, S., & Samudrala, R. K. (2019). In vitro bioactivity and degradation behaviour of β-wollastonite derived from natural waste. Materials Science and Engineering: C, 98, 109-117. https://doi.org/10.1016/j.msec.2018.12.101
Radev, L., Fernandes, M., Salvado, I., & Kovacheva, D. (2009). Organic/Inorganic bioactive materials Part III: in vitro bioactivity of gelatin/silicocarnotite hybrids. Open Chemistry, 7(4), 721-730. https://doi.org/10.2478/s11532-009-0078-z
Rezwan, K., Chen, Q. Z., Blaker, J. J., & Boccaccini, A. R. (2006). Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials, 27(18), 3413-3431. https://doi.org/10.1016/j.biomaterials.2006.01.039
Rhee, S. H., & Tanaka, J. (1998). Hydroxyapatite coating on a collagen membrane by a biomimetic method. Journal of the American Ceramic Society, 81(11), 3029-3031. https://doi.org/10.1111/j.1151-2916.1998.tb02734.x
Riaz, M., Zia, R., Aslam, S., Qamar, A., Hussain, T., & Anjum, S. (2019). Low temperature synthesis of wollastonite using sol–gel combustion method: In vitro bioactivity evaluation. International Journal of Modern Physics B, 33(10), 1950081. https://doi.org/10.1142/S0217979219500814
Touny, A. H., Laurencin, C., Nair, L., Allcock, H., & Brown, P. (2008). Formation of composites comprised of calcium deficient HAp and cross-linked gelatin. Journal of Materials Science: Materials in Medicine, 19, 3193-3201. https://doi.org/10.1007/s10856-008-3459-5
Vallet-Regí, M. (2006). Revisiting ceramics for medical applications. Dalton Transactions, (44), 5211-5220. https://doi.org/10.1039/B610219K
Wu, C., Zhang, Y., Ke, X., Xie, Y., Zhu, H., Crawford, R., & Xiao, Y. (2010). Bioactive mesopore‐glass microspheres with controllable protein‐delivery properties by biomimetic surface modification. Journal of Biomedical Materials Research Part A, 95(2), 476-485. https://doi.org/10.1002/jbm.a.32873
Zamanian, A., & Banafatizadeh, F. (2022). The effect of adding different percentages of γ-Glycidoxypropyltrimethoxysilane cross-linker on properties of freeze-dried gelatin/chitosan scaffolds with introducing Optimum Condition for Cross-linking the Chitosan/Gelatin Scaffolds for Bone Tis. Journal of Advanced Materials and Technologies 12 (2), 39-54. [In Persian] https://doi.org/10.30501/jamt.2022.347635.1229
Zhang, X., Jia, W., Gu, Y., Xiao, W., Liu, X., Wang, D., & Zhou, N. (2010). Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials, 31(22), 5865-5874. https://doi.org/10.1016/j.biomaterials.2010.04.005
Zheng, Y., Wang, C., Zhou, S., & Luo, C. (2021). The self-gelation properties of calcined wollastonite powder. Construction and Building Materials, 290, 123061. https://doi.org/10.1016/j.conbuildmat.2021.123061
Salimi,E. and Sobhani,A. (2024). Synthesis of Bioactive and Biodegradable Gelatin/Wollastonite Nanocomposite for the Delivery of Gentamicin. Journal of Advanced Materials and Technologies, 12(4), 48-60. doi: 10.30501/jamt.2023.405574.1282
MLA
Salimi,E. , and Sobhani,A. . "Synthesis of Bioactive and Biodegradable Gelatin/Wollastonite Nanocomposite for the Delivery of Gentamicin", Journal of Advanced Materials and Technologies, 12, 4, 2024, 48-60. doi: 10.30501/jamt.2023.405574.1282
HARVARD
Salimi E., Sobhani A. (2024). 'Synthesis of Bioactive and Biodegradable Gelatin/Wollastonite Nanocomposite for the Delivery of Gentamicin', Journal of Advanced Materials and Technologies, 12(4), pp. 48-60. doi: 10.30501/jamt.2023.405574.1282
CHICAGO
E. Salimi and A. Sobhani, "Synthesis of Bioactive and Biodegradable Gelatin/Wollastonite Nanocomposite for the Delivery of Gentamicin," Journal of Advanced Materials and Technologies, 12 4 (2024): 48-60, doi: 10.30501/jamt.2023.405574.1282
VANCOUVER
Salimi E., Sobhani A. Synthesis of Bioactive and Biodegradable Gelatin/Wollastonite Nanocomposite for the Delivery of Gentamicin. J. Adv. Mater. Technol., 2024; 12(4): 48-60. doi: 10.30501/jamt.2023.405574.1282